Literature DB >> 21227888

Polymorphisms of cyclo-oxygenases and 5-lipo-oxygenase-activating protein are associated with chronic spontaneous urticaria and urinary leukotriene E4.

Gabriele Di Lorenzo1, Maria Luisa Pacor, Giuseppina Candore, Florinda Listi, Vito Ditta, Maria Stefania Leto-Barone, Alberto D'Alcamo, Nicola Martinelli, Roberto Corrocher, Calogero Caruso.   

Abstract

The mechanisms of chronic spontaneous urticaria (CSU) continue to be unknown. Our working hypothesis is that polymorphisms of cyclo-oxygenases and 5-lipo-oxygenase-activating protein may be involved in the pathways leading to CSU. We examined five candidate polymorphisms of cyclo-oxygenases 1 and 2 and of 5-lipo-oxygenase-activating protein in 109 controls and in 94 CSU patients from Northern Italy. We also examined the levels of urinary leukotriene E4 (LTE4) before and after challenge with ASA. A multiple regression model was found to show that COX-2 5'UTR T/G, COX-2 Exon 10 T/C, and FLAP -336 G/A polymorphisms were significantly associated with CSU, with the minor allele more represented in CSU group. Similar results were obtained as regards the specific association with ASA-tolerated CSU and ASA-exacerbated CSU. Evaluating a polygenic model, reflecting the sum of the concomitant alleles associated with CSU (i.e. COX-2 5'UTR G allele, COX-2 Exon 10 C allele, and FLAP -336 G/A allele), the proportion of CSU patients increased progressively with the increasing number of unfavourable alleles. Finally, in a linear regression model after adjustment for disease status COX-1 22 T carriership remained a significant predictor of post-challenge high urinary LTE4 levels. Our results support the hypothesis that polymorphisms of cyclo-oxygenases and 5-lipo-oxygenase-activating protein may be associated with CSU.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21227888     DOI: 10.1684/ejd.2011.1163

Source DB:  PubMed          Journal:  Eur J Dermatol        ISSN: 1167-1122            Impact factor:   3.328


  5 in total

Review 1.  Chronic spontaneous urticaria: an autoimmune disease? A revision of the literature.

Authors:  Gabriele Di Lorenzo; Maria Stefania Leto-Barone; Simona La Piana; Aurelio Seidita; Giovam Battista Rini
Journal:  Clin Exp Med       Date:  2012-05-15       Impact factor: 3.984

2.  Effects of non-steroidal anti-inflammatory drugs and other eicosanoid pathway modifiers on antiviral and allergic responses: EAACI task force on eicosanoids consensus report in times of COVID-19.

Authors:  Milena Sokolowska; G Enrico Rovati; Zuzana Diamant; Eva Untersmayr; Jürgen Schwarze; Zuzanna Lukasik; Florentina Sava; Alba Angelina; Oscar Palomares; Cezmi A Akdis; Liam O'Mahony; Milos Jesenak; Oliver Pfaar; María José Torres; Marek Sanak; Sven-Erik Dahlén; Grzegorz Woszczek
Journal:  Allergy       Date:  2022-02-25       Impact factor: 14.710

Review 3.  Drug allergy: causes and desensitization.

Authors:  Richard Warrington
Journal:  Hum Vaccin Immunother       Date:  2012-08-24       Impact factor: 3.452

4.  Urticaria in monozygotic and dizygotic twins.

Authors:  Simon Francis Thomsen; Sophie van der Sluis; Kirsten Ohm Kyvik; Vibeke Backer
Journal:  J Allergy (Cairo)       Date:  2012-11-20

5.  Associations between vitamin D receptor gene polymorphisms and chronic spontaneous urticaria in Chinese Han population.

Authors:  Yiping Ma; Zhi Xiang; Xu Yao; Chengrang Li; Jianbing Wu; Suying Feng; Pangen Cui; Lin Lin
Journal:  Postepy Dermatol Alergol       Date:  2020-05-06       Impact factor: 1.837

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.